Safety and efficacy of local administration of contractubex® to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter comparative epidemiological cohort study in Germany

In Vivo

Volumn 20, Issue 2, 2006, Pages 277-284

  Beuth, J ^a   Hunzelmann, N ^b   van Leendert, R ^c   Basten, R ^c   Noehle, M ^d   Schneider, B ^e  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c Medical Data Research CRO   (Germany)

^d MERZ PHARMACEUTICALS GMBH   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Contratubex corticosteroid treatment; Erythema; Hypertrophic scars; Pruritus

Indexed keywords

CONTRACTUBEX; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOLOGY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; ERYTHEMA; FEMALE; GENERAL PRACTITIONER; GERMANY; HUMAN; HYPERTROPHIC SCAR; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; MULTICENTER STUDY; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN ATROPHY; SKIN PRURITUS; TELANGIECTASIA; TREATMENT OUTCOME;

EID: 33645771243     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tsao SS, Dover JS, Arndt KA and Kamuner MS: Scar management: keloid, hypertrophic, atrophic, and acne scars. Sem Cutaneous Med Surg 21: 46-75, 2002.
2. Kischer CW and Shetlar MR: Collagen and mucopolysaccharides in the hypertrophic scar. Connect Tissue Res 2: 205-213, 1974.
3. Cohen IK, Keiser HR and Sjoerdsma A: Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 22: 488-489, 1971.
4. Craig RDP, Schoefield JD and Jackson DS: Collagen biosynthesis in normal human skin and hypertrophic scars and keloid. Eur J Clin Invest 5: 69-74, 1975.
5. Brissett AE and Sherris DA: Scar contractures, hypertrophic scars, and keloids. Facial Plastic Surg 17: 263-271, 2001.
6. Craig RDP, Schoefield JD and Jackson DS: Collagen biosynthesis in normal human skin and hypertrophic scars and keloids as a function of the duration of the scar. Br J Surg 62: 741-744, 1975.
7. Willital GH and Heine H: Efficacy of Contractubex® gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol Res 14: 193-202, 1994.
8. Stein G: Erfahrungen mit der Behandlung von Keloiden und hypertrophen Narben mit Contractubex comp. Therapiewoche 40: 2299-1207, 1985.
9. Chadzynska M and Jablonska S: Therapie von verbrennungsinduzierten hypertrophischen, keloidartigen Narben bei Kindern mit Contractubex®. Dtsch Dermatol 37: 1288-1299, 1989.
10. Maragakis M, Willital GH, Michel G and Goertelmeyer R: Possibilities of scar treatment after thoracic surgery. Drugs Expl Clin Res 21: 199-206, 1995.
11. Majewski S and Chadzynska M: Effects of heparin, allantoin and cepae extract on the proliferation of keloid fibroblasts and other cells in vitro. Dermatol Monatsschr 174: 106-129, 1988.
12. Schneider B: Analysis of therapeutic efficacy in observational cohort studies. Cancer Chemother Pharmacol 47: 35-37, 2001.
13. Feunstein AR: The role of observational studies in the evaluation of therapy. Stat Med 3: 341, 1984.
14. Rosenbaum PR and Rubun DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41-55, 1983.
15. Beuth J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J and Schneider B: Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients. Results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol 47: 45-54, 2001.
16. Martin S, Kolb H, Beuth J, van Leendert R, Schneider B and Scherbaum WA: Change in patients' body weight after 12 months of treatment with glimepirid or glibenclamide in Type 2 diabetes: a multicentre retrolective cohort study. Diabetologia 46: 1611-1617, 2003.
17. Schumacher K, Schneider B, Reich G, Stiefel T, Stoll G, Bock PR, Hanisch J and Beuth J: Influence of postoperative treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentre cohort study. Anticancer Res 23: 5081-5088, 2003.
18. Baryza MJ and Baryza GA: The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16: 535-538, 1995.
19. Shaffer JJ, Taylor SC and Cook-Bolden F: Keloidal scars: a review with critical look at therapeutic options. J Am Acad Dermatol 46: 63-97, 2002.
20. Berman B and Flores F: The treatment of hypertrophic scars. Eur J Dermatol 8: 591-596, 1998.
21. Elnina EL, Ahmed SA, Abdel G, Mekkawi AG and Mossa JS: The antimicrobial activity of garlic and onion extract. Pharmazie 38: 747-748, 1983.
22. Fisher AA: Allantoin - a non-sensitizing topical medicament. Therapeutic effects of the addition of 5 percent allantoin to vaseline. Cutis 27: 230-234, 1981.
23. Dollery C: Therapeutic Drugs. Volume 1. Heparin Sodium and Heparin Calcium. 2nd edition. Churchill Livingstone Edinburgh, London, New York, Philadelphia, San Francisco, Sydney, 1999.
24. Horwitz RI, Viscoli CM, Clemens JD and Saddock RT: Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 89: 630-638, 1990.
25. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127: 757-763, 1997.
26. Benson K and Hartz AJ: A comparison of observational studies and randomized controlled trials. N Engl J Med 342: 1878-1886, 2000.
27. Concato J, Shah N and Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research design. N Engl J Med 342: 1887-1892, 2000.